Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Plasma cell 4Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Leukemia 42Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 22Leukemia, Myeloid, Acute 21Lung Neoplasms 19Congenital Abnormalities 17Kidney Neoplasms 16Rectal Neoplasms 15Lymphoma 15Head and Neck Neoplasms 15Colorectal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Melanoma 14Colonic Neoplasms 14Sarcoma 13Lymphoma, Follicular 11Carcinoma, Renal Cell 11Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Prostatic Neoplasms 9Leukemia, Myelomonocytic, Acute 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Central Nervous System Neoplasms 9Multiple Myeloma 8Leukemia, Lymphocytic, Chronic, B-Cell 7Gliosarcoma 7Glioblastoma 7Esophageal Neoplasms 7

Interventions

Dexamethasone 111Cyclophosphamide 99Melphalan 91Bortezomib 69Peripheral Blood Stem Cell Transplantation 64Lenalidomide 58fludarabine phosphate 56Busulfan 54Filgrastim 50Tacrolimus 38Antilymphocyte Serum 38Thalidomide 36Radiotherapy 36Mycophenolic Acid 33fludarabine 28Cyclosporine 26Methotrexate 25Etoposide 22Calcium Dobesilate 22Whole-Body Irradiation 21Prednisone 21Methylprednisolone 20sargramostim 19pomalidomide 19Granulocyte Colony-Stimulating Factor 18carfilzomib 16daratumumab 15Cord Blood Stem Cell Transplantation 15Carmustine 14Rituximab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Gene Expression Profiling × Clear all
NCT00899080 2017-05-17

Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide

Eastern Cooperative Oncology Group

Completed
33 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00942422 2015-03-27

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Barbara Ann Karmanos Cancer Institute

Phase 2 Terminated
8 enrolled 5 charts
Other neoplasmPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Precancerous Conditions, Neoplasms, Plasma Cell

NCT00900406 2012-11-06

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Vanderbilt-Ingram Cancer Center

Completed
190 enrolled
BreastCNSGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmPlasma cell

Testicular Germ Cell Tumor, Breast Neoplasms, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neuroblastoma, Ovarian Neoplasms, Gestational Trophoblastic Disease, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases

NCT00482495 2011-05-11

Bevacizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Mayo Clinic

Phase 2 Completed
42 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡